Linear IgA bullous dermatosis

Lesions on the skin, mucous membranes, or both may be seen in cases with linear IgA bullous dermatosis (LABD). While LABD can affect both adults and children, there are variations in the disease's clinical features between these two groups of people. The most common symptom of LABD of childhood, also called chronic bullous disease of childhood, is the sudden growth of vesicles or bullae on areas of skin that are either inflammatory or not. An arciform or annular appearance is frequently the consequence of new blisters forming at the margins of lesions that are healing. Skin lesions typically occur in a wide range of locations, including the hands, feet, genitalia, trunk, and face, especially the perioral area. The lower abdomen, inner thighs, and perineum are frequently the most severely affected areas. Children who are affected may show no symptoms, yet pruritus is frequent and can get quite bad. For certain people, severe itching signals the beginning of the illness again. Adult patients with LABD usually have a sudden onset of skin lesions; however, the condition can develop more slowly. Bullae and tight vesicles can form inside inflammatory plaques or on healthy skin. Adults experience a lower incidence of developing annular lesions exhibiting peripheral vesiculation compared to children. Lesion formation is prevalent in the trunk, extensor extremities, buttocks, and face (especially the perioral area). There have also been reports of localized variations of LABD that manifest as annular inflammatory plaques or restricted blistering eruptions. Strong pruritus may cause excoriated papules or lesions resembling prurigo nodularis to appear. Both adults and children can experience mucous membrane involvement. Up to 80% of adult patients experience mucosal illness. The mucosal areas most frequently affected are the oral and ocular mucosa. Conjunctival redness, ocular discharge, ocular pain, or a feeling of a foreign body can all be symptoms of ocular illness. == Causes ==

Circulating IgA anti-basement membrane zone antibodies directed against the 97 kDa component of BPAG2 (bullous pemphigoid antigen 2) in the lamina lucida are the primary cause of linear IgA bullous dermatosis (LABD). Risk factors The most frequent benign condition linked to LABD is ulcerative colitis. It is unknown why there is a correlation between ulcerative colitis and LABD. According to some writers, aberrant IgA1 production by the inflamed colon may have a role in the emergence of LABD. Many case reports have documented the incidence of LABD in conjunction with solid organ cancers and lymphoproliferative diseases. Psoriasis, systemic lupus erythematosus, and a number of infections have also been linked to LABD in a small number of patients. There have also been reports of LABD developing after UV radiation exposure. Triggers Drug exposure has been shown in several case reports to be a contributing factor. The pharmacologic medication most commonly mentioned as a possible initiating cause is vancomycin. A number of antibiotics, nonsteroidal anti-inflammatory medications, lithium, amiodarone, captopril, cyclosporine, phenytoin, interferon alfa, furosemide, and somatostatin are a few other medications that may be connected to LABD. Genetics Development of LABD may also be influenced by genetic factors. There have been reports of associations between LABD and the tumor necrosis factor-2 allele, human leukocyte antigen (HLA) B8, HLA Cw7, HLA DR3, and HLA DQ2. == Mechanism ==

While it is acknowledged that one of the hallmarks of linear IgA bullous dermatosis (LABD) is the presence of IgA antibodies linked to the basement membrane zone, the process by which lesions occur in this condition is not well known. The pathophysiology of this disease may involve both cellular and humoral immune responses. IgA antibodies directed against various basement membrane antigens, such as type VII collagen (COL7), laminin-332, or laminin gamma 1, are present in certain patients with LABD. The target antigen in certain people with vancomycin-induced LABD appears to be type VII collagen. == Diagnosis ==

The clinical manifestations of various mucocutaneous disorders may be confused with those of linear IgA bullous dermatosis (LABD). Therefore, laboratory studies are usually used to confirm the diagnosis when available. The gold standard for diagnosing LABD is the detection of linear IgA deposits along the basement membrane zone using direct immunofluorescence (DIF), even though the results of a regular histopathologic examination of the affected tissue may suggest LABD. Linear IgA bullous dermatosis histopathologic features are vague and frequently mimic dermatitis herpetiformis. Characteristic is a subepidermal blister with an underlying dermal infiltration that is primarily composed of neutrophils. There may also be papillary microabscesses, eosinophils, and lymphocytes that resemble those found in dermatitis herpetiformis. == Treatment ==

First-line treatment for LABD is thought to be dapsone, an immunomodulatory sulfone that has been successfully used to treat a variety of dermatologic illnesses marked by neutrophilic infiltrates. Treatment with sulfapyridine or sulfamethoxypyridazine, sulfonamide drugs with chemical similarities to dapsone, may be beneficial for patients who cannot tolerate dapsone. == Gallery ==

File:Micrograph of linear IgA bullous dermatosis.jpg|Micrograph: Subepidermal blister formation and neutrophils File:IgA bullous dermatosis.jpg == See also ==